ICD-10 Coding for Lung Cancer with Metastasis(C34.10U, C34.12, C34.90)
Learn about ICD-10 coding for lung cancer with metastasis, including primary and secondary codes, sequencing rules, and documentation requirements.
Complete code families applicable to Lung Cancer with Metastasis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C34.90 | Malignant neoplasm of unspecified part of bronchus or lung | Use when the specific site of the lung cancer is not documented. |
|
| C78.00 | Secondary malignant neoplasm of unspecified lung | Use when lung is a secondary site and specific lung site is not documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutLung Cancer with Metastasis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Lung Cancer with Metastasis.
Using unspecified codes when specific sites are documented.
Impact
Clinical: May lead to inappropriate treatment decisions., Regulatory: Non-compliance with coding standards., Financial: Potential loss of reimbursement due to lack of specificity.
Mitigation
Review documentation for specific site details., Educate providers on importance of specificity.
Incorrect sequencing of primary and secondary codes.
Impact
Reimbursement: Incorrect sequencing can affect DRG assignment and reimbursement., Compliance: May lead to non-compliance with coding guidelines., Data Quality: Affects accuracy of patient records and data reporting.
Mitigation
Sequence based on treatment focus: secondary first if treatment is directed at metastasis.
Incorrect code sequencing
Impact
Sequencing errors in primary vs. secondary neoplasm coding.
Mitigation
Regular training on sequencing rules and documentation review.